158 related articles for article (PubMed ID: 38777829)
21. Organoids.
Zhao Z; Chen X; Dowbaj AM; Sljukic A; Bratlie K; Lin L; Fong ELS; Balachander GM; Chen Z; Soragni A; Huch M; Zeng YA; Wang Q; Yu H
Nat Rev Methods Primers; 2022; 2():. PubMed ID: 37325195
[TBL] [Abstract][Full Text] [Related]
22. Robust generation of human-chambered cardiac organoids from pluripotent stem cells for improved modelling of cardiovascular diseases.
Ho BX; Pang JKS; Chen Y; Loh YH; An O; Yang HH; Seshachalam VP; Koh JLY; Chan WK; Ng SY; Soh BS
Stem Cell Res Ther; 2022 Dec; 13(1):529. PubMed ID: 36544188
[TBL] [Abstract][Full Text] [Related]
23. Heart organoids and tissue models for modeling development and disease.
Miyamoto M; Nam L; Kannan S; Kwon C
Semin Cell Dev Biol; 2021 Oct; 118():119-128. PubMed ID: 33775518
[TBL] [Abstract][Full Text] [Related]
24. Impact of Micro- and Nano-Plastics on Human Intestinal Organoid-Derived Epithelium.
Wang B; Iglesias-Ledon L; Bishop M; Chadha A; Rudolph SE; Longo BN; Cairns DM; Chen Y; Kaplan DL
Curr Protoc; 2024 Apr; 4(4):e1027. PubMed ID: 38588063
[TBL] [Abstract][Full Text] [Related]
25. Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?
Shiota J; Samuelson LC; Razumilava N
Hepatology; 2021 Oct; 74(4):2251-2263. PubMed ID: 33638203
[TBL] [Abstract][Full Text] [Related]
26. Transformational Applications of Human Cardiac Organoids in Cardiovascular Diseases.
Xuan W; Tipparaju SM; Ashraf M
Front Cell Dev Biol; 2022; 10():936084. PubMed ID: 35813193
[TBL] [Abstract][Full Text] [Related]
27. Engineering spatial-organized cardiac organoids for developmental toxicity testing.
Hoang P; Kowalczewski A; Sun S; Winston TS; Archilla AM; Lemus SM; Ercan-Sencicek AG; Gupta AR; Liu W; Kontaridis MI; Amack JD; Ma Z
Stem Cell Reports; 2021 May; 16(5):1228-1244. PubMed ID: 33891865
[TBL] [Abstract][Full Text] [Related]
28. From engineered heart tissue to cardiac organoid.
Cho J; Lee H; Rah W; Chang HJ; Yoon YS
Theranostics; 2022; 12(6):2758-2772. PubMed ID: 35401829
[TBL] [Abstract][Full Text] [Related]
29. Engineering approaches for cardiac organoid formation and their characterization.
Joddar B; Natividad-Diaz SL; Padilla AE; Esparza AA; Ramirez SP; Chambers DR; Ibaroudene H
Transl Res; 2022 Dec; 250():46-67. PubMed ID: 35995380
[TBL] [Abstract][Full Text] [Related]
30. A Robust Pipeline for the Multi-Stage Accelerated Differentiation of Functional 3D Cortical Organoids from Human Pluripotent Stem Cells.
Whye D; Wood D; Saber WA; Norabuena EM; Makhortova NR; Sahin M; Buttermore ED
Curr Protoc; 2023 Jan; 3(1):e641. PubMed ID: 36633423
[TBL] [Abstract][Full Text] [Related]
31. Prediction of Acute Hepatotoxicity With Human Pluripotent Stem Cell-Derived Hepatic Organoids.
Kim H; Kim SK; Oelgeschläger M; Park HJ
Curr Protoc; 2024 Apr; 4(4):e1015. PubMed ID: 38597874
[TBL] [Abstract][Full Text] [Related]
32. Brain Organoid Generation from Induced Pluripotent Stem Cells in Home-Made Mini Bioreactors.
Eremeev A; Belikova L; Ruchko E; Volovikov E; Zubkova O; Emelin A; Deev R; Lebedeva O; Bogomazova A; Lagarkova M
J Vis Exp; 2021 Dec; (178):. PubMed ID: 34958079
[TBL] [Abstract][Full Text] [Related]
33. Ethical Challenges in Organoid Use.
Mollaki V
BioTech (Basel); 2021 Jun; 10(3):. PubMed ID: 35822766
[TBL] [Abstract][Full Text] [Related]
34. Heart Organoids and Engineered Heart Tissues: Novel Tools for Modeling Human Cardiac Biology and Disease.
Lewis-Israeli YR; Wasserman AH; Aguirre A
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572490
[TBL] [Abstract][Full Text] [Related]
35. Better Being Single? Omics Improves Kidney Organoids.
Freedman BS
Nephron; 2019; 141(2):128-132. PubMed ID: 30554217
[TBL] [Abstract][Full Text] [Related]
36. Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease.
Zhu L; Liu K; Feng Q; Liao Y
Stem Cell Rev Rep; 2022 Dec; 18(8):2593-2605. PubMed ID: 35525908
[TBL] [Abstract][Full Text] [Related]
37. Human chemically-derived hepatic progenitors (hCdHs) as a source of liver organoid generation: Application in regenerative medicine, disease modeling, and toxicology testing.
Salas-Silva S; Kim Y; Kim TH; Kim M; Seo D; Choi J; Factor VM; Seo HR; Song Y; Choi GS; Jung YK; Kim K; Lee KG; Jeong J; Shin JH; Choi D
Biomaterials; 2023 Dec; 303():122360. PubMed ID: 38465578
[TBL] [Abstract][Full Text] [Related]
38. Navigating the kidney organoid: insights into assessment and enhancement of nephron function.
Tabibzadeh N; Satlin LM; Jain S; Morizane R
Am J Physiol Renal Physiol; 2023 Dec; 325(6):F695-F706. PubMed ID: 37767571
[TBL] [Abstract][Full Text] [Related]
39. A review of protocols for brain organoids and applications for disease modeling.
Mayhew CN; Singhania R
STAR Protoc; 2023 Mar; 4(1):101860. PubMed ID: 36566384
[TBL] [Abstract][Full Text] [Related]
40. Pluripotent stem cells for target organ developmental toxicity testing.
Wu X; Chen Y; Kreutz A; Silver B; Tokar EJ
Toxicol Sci; 2024 May; 199(2):163-171. PubMed ID: 38547390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
